Call for Abstracts: The Lancet Palestinian Health Alliance (LPHA) Twelfth Annual Conference

The Institute of Community and Public Health (ICPH) at Birzeit University (BZU), in collaboration with the Faculty of Health Sciences (FHS) at the American University of Beirut (AUB), is pleased to invite submissions of abstracts for presentation at the upcoming LPHA 2022 Twelfth Annual Conference “Health of Palestinians,” which will be held from remote on 21-24 November 2022.

The LPHA comprises a collaboration of Palestinian, regional and international researchers, committed to the highest scientific standards in describing, analyzing and evaluating the health and health care of Palestinians, in order to contribute to the international scientific literature and to develop local evidence-based policy and practices. Activities include: developing measurement and other scientific methods that are culture-specific; increasing capacity for research; encouraging advocacy based on science; and promoting academic collaboration within the occupied Palestinian territory, across the region, and the globe.

For the LPHA’s twelfth Annual Conference, of priority interest are studies that address issues of current relevance to Palestinian health involving new ideas and approaches, using rigorous methodology, and providing results within a policy framework. The focus of studies can be on  issues of relevance to the following four major themes:1)  aspects of health that have been impacted by the Israeli occupation; 2) social and political determinants, as well as biological, behavioral, health services and environmental  factors influencing health; 3) human security, equity, and human rights as principles that govern health; and 4) evaluations of clinical and public health practices


Abstracts should be between 400-500 words in length, and written in English. The expectation is that structured abstracts will be appropriate for most of the summaries of research submitted. These should include a. Background, b. Methods, c. Findings, and d. Interpretation whenever appropriate. PLease see Guidelines 


In the background section, authors are expected to include a brief summary of what they found in the literature and what inspired their research. All clinical trials need to be registered. Ethical permissions are required where appropriate. Abstracts should also include the full names and affiliations of all abstract authors, and the email address of the corresponding author.




Abstracts should be submitted using the link below no later than May 15 2022. They will be peer reviewed by an expert committee composed of Palestinian, regional and international scientists. Any abstract that relates to a study for which data are currently unavailable but expected to be available for presentation at the conference should be accompanied by a copy of the study protocol. 


Participants will be informed by end of July 2022 whether their submission has been successful in being selected for presentation at the conference, either as oral presentations, or as posters. Selected abstracts will be collated and distributed by email to conference attendees.  


Authors of selected abstracts should submit recordings for oral presentations to support a 15-minute presentation, or the full text for poster presentations. These should be sent by email, no later than September 30, 2022. Deadlines will be strictly adhered to.


To submit abstracts please follow the following


If you have any questions or problems submitting your abstract please contact us at [email protected]